Peptide Decoding
New?New to peptides?Start here →
Decoding

Tuftsin_Dosage, benefits & legal status

Also known as TKPR, Thr-Lys-Pro-Arg, tuftsin peptide

Published August 24, 2026

A four-amino-acid immune peptide from the 1970s, and the parent of Selank.

Immune supportImmune tetrapeptideResearch only
DoseResearch only
FrequencyNot established
RouteUnder the skin (subcutaneous)
StatusResearch only
CycledNot established

Common vial size is what vendors typically sell, not a recommendation. Enter your own vial in the calculator.

See how this dose compares across the library →

01

What is Tuftsin?

Plain language first. The technical label stays, but it never stands alone.

Overview

A four-amino-acid immune peptide from the 1970s. Selank was built from it precisely because tuftsin itself falls apart too fast to be useful.

The technical version

Tuftsin (Thr-Lys-Pro-Arg), a tetrapeptide derived from the CH2 domain of the immunoglobulin G heavy chain, described as a phagocytosis-stimulating factor. Parent molecule of the Russian-registered anxiolytic Selank. No modern controlled human trial of tuftsin administration has been published outside its original research era.

What it's used for

An immune peptide researched for stimulating phagocytes, and the molecule Selank was designed from.

02

How does Tuftsin work?

What it does in the body, and where.

Tuftsin is one of the older compounds in this library and the connection to Selank is the most useful thing about it.

  1. 01
    It comes from an antibody
    Tuftsin is a tetrapeptide released from the heavy chain of immunoglobulin G, named after Tufts University where it was described in the 1970s.
  2. 02
    Its documented action is on phagocytes
    Reported to stimulate macrophages and neutrophils to engulf and destroy bacteria, which is the basis of the immune claims made for it.
  3. 03
    Selank is tuftsin with a tail
    The Russian anxiolytic Selank, which this library covers, is a tuftsin analog with additional residues added for stability. Selank's evidence belongs to Selank and does not transfer back to the parent.
03

What else is it used for?

Each use below carries its own evidence level. Approved means regulators have cleared it for that purpose. Investigational means it is in trials. Early research means it is being studied and is not established.

  • Stimulating phagocytes, the cells that engulf bacteriaEarly research
  • Immune support generallyResearch only
  • As the parent molecule of SelankClinical use

The published record

Research index

647

Papers and trials about Tuftsin

165 papers tagged human · 100 not reviews or lab · 3 clinical trial publications

Furthest stage reached: Published trials only, 3 clinical trial publications, no phased trial registered

Compare this against the whole library →

In animals295
In the lab72
Reviews28
Senior author shareSpread across many groups

Evidence summary

Counted from Europe PMC indexing, not read by a person; a human tag can land on reviews, commentary or lab papers; clinical trial publications is the narrower count. 442 papers and 0 trials indexed in detail.

Tuftsin vial rendering
Compound field notes

At a glance

Four things to know about Tuftsin

01

Evidence

Research only

02

Category

Immune support

03

Common vial

Varies

04

Half-life

Nothing published

04

How much, and do you cycle it?

The range, and whether you take breaks.

Research only, not established. Not established No range

No schedule has been studied for this compound in people.

Compare this against the whole library →

05

How long does it stay in the body?

The half-life, and where the figure comes from.

Nothing publishedNo figure

No reliable half-life for administered tuftsin in people was located.

You can compare this against the whole library to see where it sits.

06

How do I dose and price it?

Enter your vial and your dose. Pick a mix. We show the draw and the cost.

The vial holds a fixed amount of drug. Adding more water does not make more drug, it just spreads it thinner, so you draw a bigger number on the syringe for the same dose.

Your vial size (mg)
Printed on the vial.
What you paid per vial
$
Used for cost per dose only.
Your dose (mg)
Commonly referenced dose: 5 mgCommunity practice

Choose your mix

your own mL
units · —
Enter your own volume

Measuring the water1 mL = one full 100-unit syringe.

YOUR DRAW100 / 100 units
07

How do you store it?

Before mixing, and after.

Dry powder in the freezer or fridge. Once mixed, fridge, and use within about a month.

Unmixed lyophilized Tuftsin keeps for a long time cold. Once you add water the clock starts: most reconstituted vials hold up for roughly 28 to 30 days at fridge temperature. Keep it out of light, and do not freeze it after mixing.

08

What are the side effects and cautions?

Known cautions and warnings for this compound.

Who should avoid it

Check these before anything else.
  • Pregnancy or breastfeeding
  • An autoimmune condition, where stimulating immune cells is a poor idea without advice
  • Immunosuppressant medication, including after a transplant
  • Anyone who wants established safety data, because none exists for this compound in humans

Stop and get help

These are emergencies. Seek care.
  • Signs of an allergic reaction, including spreading hives, facial or throat swelling, or trouble breathing
  • Redness, heat, or pus at the injection site, which can signal infection
  • Anything unusual, since there is no known safety profile to compare it against

Common effects

Expected, and usually mild.
  • Unknown. No study has recorded what this commonly causes in people
  • Redness, soreness, or a small bump at the injection site

Where this page says nothing is established, that means nobody has studied it, not that a compound is safe.

09

Is Tuftsin approved?

And where the numbers on this page come from.

No. Tuftsin is not approved for any use, anywhere. It is sold labeled for laboratory research only, and there is no legal route to buy it for human use.

  • Approval status
    Research only
  • Route
    Under the skin (subcutaneous)
  • Checked
    24 August 2026
  • Dose
    From community reports. No regulator or trial established this dose.
  • Vial size
    From what vendors typically list; not a recommendation.
  • Sources
    None traced yet.

What has happened recently

We have not yet written a full regulatory note for this compound. The status above is current as of the date shown.

Guides for this compound

Sources

No primary source has been traced for this compound yet. Treat everything on this page as unverified until one is. How we grade evidence

Beyond these, 442 records are indexed. Browse the records